Serum levels of soluble suppression of tumorigenicity 2 (sST2) and heart-type fatty acid binding protein (H-FABP) independently predict in-hospital mortality in geriatric patients with COVID-19
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved..
Elevation of cardiac damage biomarkers is associated with adverse clinical outcomes and increased mortality in COVID-19 patients. This study assessed the association of admission serum levels of sST2 and H-FABP with in-hospital mortality in 191 geriatric patients (median age 86 yrs., IQR 82-91 yrs.) with COVID-19 and available measures of hs-cTnT and NT-proBNP at admission. Cox proportional hazards models were utilized to predict in-hospital mortality, considering clinical/biochemical confounders as covariates. A composite cardiac score was calculated to improve predictive accuracy. Patients deceased during their hospital stay (26%) exhibited higher levels of all biomarkers, which demonstrated good discrimination for in-hospital mortality. Addition of sST2 and H-FABP significantly improved the discriminatory power of hs-cTnT and NT-proBNP. The composite cardiac score (AUC=0.866) further enhanced the predictive accuracy. Crude and adjusted Cox regressions models revealed that both sST2 and H-FABP were independently associated with in-hospital mortality (HR for sST2 ≥129 ng/mL, 4.32 [1.48-12.59]; HR for H-FABP ≥18 ng/mL, 7.70 [2.12-28.01]). The composite cardiac score also independently correlated with in-hospital mortality (HR for 1-unit increase, 1.47 [1.14-1.90]). In older patients with COVID-19, sST2 and H-FABP demonstrated prognostic value, improving the predictive accuracy of the routinely assessed biomarkers hs-cTnT and NT-proBNP.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:216 |
---|---|
Enthalten in: |
Mechanisms of ageing and development - 216(2023) vom: 15. Dez., Seite 111876 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sabbatinelli, Jacopo [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 21.12.2023 Date Revised 21.12.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.mad.2023.111876 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362960933 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM362960933 | ||
003 | DE-627 | ||
005 | 20231227135319.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.mad.2023.111876 |2 doi | |
028 | 5 | 2 | |a pubmed24n1234.xml |
035 | |a (DE-627)NLM362960933 | ||
035 | |a (NLM)37802485 | ||
035 | |a (PII)S0047-6374(23)00102-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sabbatinelli, Jacopo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Serum levels of soluble suppression of tumorigenicity 2 (sST2) and heart-type fatty acid binding protein (H-FABP) independently predict in-hospital mortality in geriatric patients with COVID-19 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.12.2023 | ||
500 | |a Date Revised 21.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved. | ||
520 | |a Elevation of cardiac damage biomarkers is associated with adverse clinical outcomes and increased mortality in COVID-19 patients. This study assessed the association of admission serum levels of sST2 and H-FABP with in-hospital mortality in 191 geriatric patients (median age 86 yrs., IQR 82-91 yrs.) with COVID-19 and available measures of hs-cTnT and NT-proBNP at admission. Cox proportional hazards models were utilized to predict in-hospital mortality, considering clinical/biochemical confounders as covariates. A composite cardiac score was calculated to improve predictive accuracy. Patients deceased during their hospital stay (26%) exhibited higher levels of all biomarkers, which demonstrated good discrimination for in-hospital mortality. Addition of sST2 and H-FABP significantly improved the discriminatory power of hs-cTnT and NT-proBNP. The composite cardiac score (AUC=0.866) further enhanced the predictive accuracy. Crude and adjusted Cox regressions models revealed that both sST2 and H-FABP were independently associated with in-hospital mortality (HR for sST2 ≥129 ng/mL, 4.32 [1.48-12.59]; HR for H-FABP ≥18 ng/mL, 7.70 [2.12-28.01]). The composite cardiac score also independently correlated with in-hospital mortality (HR for 1-unit increase, 1.47 [1.14-1.90]). In older patients with COVID-19, sST2 and H-FABP demonstrated prognostic value, improving the predictive accuracy of the routinely assessed biomarkers hs-cTnT and NT-proBNP | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Geriatric patients | |
650 | 4 | |a Heart-type fatty acid binding protein | |
650 | 4 | |a In-hospital mortality | |
650 | 4 | |a Soluble ST2 | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Fatty Acid Binding Protein 3 |2 NLM | |
650 | 7 | |a IL1RL1 protein, human |2 NLM | |
650 | 7 | |a Peptide Fragments |2 NLM | |
650 | 7 | |a FABP3 protein, human |2 NLM | |
700 | 1 | |a Di Rosa, Mirko |e verfasserin |4 aut | |
700 | 1 | |a Giuliani, Angelica |e verfasserin |4 aut | |
700 | 1 | |a Domenichelli, Marco |e verfasserin |4 aut | |
700 | 1 | |a Bonfigli, Anna Rita |e verfasserin |4 aut | |
700 | 1 | |a Sarzani, Riccardo |e verfasserin |4 aut | |
700 | 1 | |a Cherubini, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Antonicelli, Roberto |e verfasserin |4 aut | |
700 | 1 | |a Burattini, Maurizio |e verfasserin |4 aut | |
700 | 1 | |a Corsonello, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Galeazzi, Roberta |e verfasserin |4 aut | |
700 | 1 | |a Babini, Lucia |e verfasserin |4 aut | |
700 | 1 | |a Moretti, Marco |e verfasserin |4 aut | |
700 | 1 | |a Procopio, Antonio Domenico |e verfasserin |4 aut | |
700 | 1 | |a Lattanzio, Fabrizia |e verfasserin |4 aut | |
700 | 1 | |a Olivieri, Fabiola |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Mechanisms of ageing and development |d 1973 |g 216(2023) vom: 15. Dez., Seite 111876 |w (DE-627)NLM000007528 |x 1872-6216 |7 nnns |
773 | 1 | 8 | |g volume:216 |g year:2023 |g day:15 |g month:12 |g pages:111876 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mad.2023.111876 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 216 |j 2023 |b 15 |c 12 |h 111876 |